Reply to: Comment on De Giorgis et al. “Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome-Associated Paroxysmal Movement Disorders”
Reply to: Comment on De Giorgis et al. “Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome-Associated Paroxysmal Movement Disorders”

Reply to: Comment on De Giorgis et al. “Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome-Associated Paroxysmal Movement Disorders”

Mov Disord. 2024 Oct;39(10):1899-1900. doi: 10.1002/mds.29985.

NO ABSTRACT

PMID:39425523 | DOI:10.1002/mds.29985